IL121733A - The fermentation process is osmotically controlled for the preparation of acarbose - Google Patents
The fermentation process is osmotically controlled for the preparation of acarboseInfo
- Publication number
- IL121733A IL121733A IL12173397A IL12173397A IL121733A IL 121733 A IL121733 A IL 121733A IL 12173397 A IL12173397 A IL 12173397A IL 12173397 A IL12173397 A IL 12173397A IL 121733 A IL121733 A IL 121733A
- Authority
- IL
- Israel
- Prior art keywords
- osmolality
- fermentation
- nutrient solution
- acarbose
- culture
- Prior art date
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 66
- 230000004151 fermentation Effects 0.000 title claims abstract description 66
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 title claims abstract description 39
- 229960002632 acarbose Drugs 0.000 title claims abstract description 39
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title description 4
- 235000015097 nutrients Nutrition 0.000 claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 27
- 230000008569 process Effects 0.000 claims abstract description 16
- 239000000470 constituent Substances 0.000 claims abstract description 6
- 239000001963 growth medium Substances 0.000 claims abstract 7
- 238000012544 monitoring process Methods 0.000 claims abstract 2
- 238000010924 continuous production Methods 0.000 claims description 5
- 238000010923 batch production Methods 0.000 claims description 4
- 239000000243 solution Substances 0.000 description 48
- 239000000758 substrate Substances 0.000 description 21
- 229920002472 Starch Polymers 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- 235000019698 starch Nutrition 0.000 description 9
- 239000000413 hydrolysate Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000002349 favourable effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000008399 tap water Substances 0.000 description 6
- 235000020679 tap water Nutrition 0.000 description 6
- 238000011217 control strategy Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229930000044 secondary metabolite Natural products 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 108010079058 casein hydrolysate Proteins 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 241000187844 Actinoplanes Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 125000003071 maltose group Chemical group 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000024053 secondary metabolic process Effects 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19637591A DE19637591A1 (de) | 1996-09-13 | 1996-09-13 | Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL121733A0 IL121733A0 (en) | 1998-02-22 |
| IL121733A true IL121733A (en) | 2001-05-20 |
Family
ID=7805705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12173397A IL121733A (en) | 1996-09-13 | 1997-09-10 | The fermentation process is osmotically controlled for the preparation of acarbose |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6130072A (fr) |
| EP (1) | EP0829541B1 (fr) |
| JP (2) | JP4623766B2 (fr) |
| KR (1) | KR100463738B1 (fr) |
| CN (1) | CN1113966C (fr) |
| AT (1) | ATE264919T1 (fr) |
| CA (1) | CA2215605C (fr) |
| DE (2) | DE19637591A1 (fr) |
| DK (1) | DK0829541T3 (fr) |
| ES (1) | ES2217354T3 (fr) |
| HU (1) | HU223576B1 (fr) |
| IL (1) | IL121733A (fr) |
| PT (1) | PT829541E (fr) |
| TW (1) | TW349124B (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112646850A (zh) * | 2021-01-26 | 2021-04-13 | 石药集团圣雪葡萄糖有限责任公司 | 一种提高阿卡波糖发酵产量的方法 |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19844924A1 (de) * | 1998-09-30 | 2000-04-06 | Bayer Ag | Immobilisierte Zellen von Actinoplanes acarbosefaciens SE 50/110, Immobilisierungsverfahren und Verwendung des Immobilisats zur Herstellung von Acarbose |
| US6849609B2 (en) | 2001-04-10 | 2005-02-01 | James U. Morrison | Method and composition for controlled release acarbose formulations |
| CN101603066B (zh) * | 2008-06-13 | 2013-06-05 | 上海医药工业研究院 | 一种阿卡波糖的制备方法 |
| CN102220396B (zh) * | 2011-04-27 | 2013-07-24 | 江西农业大学 | 阿卡波糖简易的发酵方法 |
| CN102559814B (zh) * | 2012-03-02 | 2015-11-25 | 丽珠集团新北江制药股份有限公司 | 一种制备阿卡波糖的方法 |
| CN112048532B (zh) * | 2020-09-18 | 2022-07-15 | 山东鲁抗医药股份有限公司 | 一种发酵生产阿卡波糖的方法 |
| CN116262937A (zh) * | 2021-12-13 | 2023-06-16 | 杭州中美华东制药江东有限公司 | 一种提高阿卡波糖生物发酵水平的方法 |
| CN115161365B (zh) * | 2022-09-08 | 2023-01-06 | 上海现代制药股份有限公司 | 一种提高阿卡波糖产量的发酵工艺 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2064092C2 (de) * | 1970-12-28 | 1983-06-01 | Bayer Ag, 5090 Leverkusen | Inhibitoren für Glykosidhydrolasen aus Actinomyceten |
| US4062950A (en) * | 1973-09-22 | 1977-12-13 | Bayer Aktiengesellschaft | Amino sugar derivatives |
| DE2347782C3 (de) * | 1973-09-22 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| GB1544068A (en) * | 1977-03-30 | 1979-04-11 | Bayer Ag | Amino-sugar derivatives |
| DE2719912C3 (de) * | 1977-05-04 | 1979-12-06 | Bayer Ag, 5090 Leverkusen | Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen |
| US4724206A (en) * | 1984-02-13 | 1988-02-09 | Damon Biotech, Inc. | Protein production using hypertonic media |
| JP2718726B2 (ja) * | 1988-12-16 | 1998-02-25 | 三井東圧化学株式会社 | ヒト組織型プラスミノーゲン活性化因子の製法 |
| JPH05211882A (ja) * | 1991-12-11 | 1993-08-24 | Ajinomoto Co Inc | トレハロースの製造法 |
| KR940008059B1 (ko) * | 1992-08-28 | 1994-09-01 | 기아특수강 주식회사 | 노르말라이징에 의한 강인, 고청정 비조질 중형봉강의 제조방법 |
| DE19507214A1 (de) * | 1995-03-02 | 1996-10-31 | Bayer Ag | Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung |
-
1996
- 1996-09-13 DE DE19637591A patent/DE19637591A1/de not_active Withdrawn
-
1997
- 1997-08-20 TW TW086111877A patent/TW349124B/zh not_active IP Right Cessation
- 1997-09-01 PT PT97115091T patent/PT829541E/pt unknown
- 1997-09-01 DK DK97115091T patent/DK0829541T3/da active
- 1997-09-01 ES ES97115091T patent/ES2217354T3/es not_active Expired - Lifetime
- 1997-09-01 AT AT97115091T patent/ATE264919T1/de active
- 1997-09-01 EP EP97115091A patent/EP0829541B1/fr not_active Expired - Lifetime
- 1997-09-01 DE DE59711536T patent/DE59711536D1/de not_active Expired - Lifetime
- 1997-09-05 US US08/924,157 patent/US6130072A/en not_active Expired - Lifetime
- 1997-09-08 JP JP25797997A patent/JP4623766B2/ja not_active Expired - Lifetime
- 1997-09-10 IL IL12173397A patent/IL121733A/en not_active IP Right Cessation
- 1997-09-10 CA CA002215605A patent/CA2215605C/fr not_active Expired - Fee Related
- 1997-09-12 KR KR1019970047096A patent/KR100463738B1/ko not_active IP Right Cessation
- 1997-09-12 HU HU9701539A patent/HU223576B1/hu active IP Right Grant
- 1997-09-12 CN CN97118621A patent/CN1113966C/zh not_active Expired - Lifetime
-
2007
- 2007-10-10 JP JP2007264160A patent/JP2008054688A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112646850A (zh) * | 2021-01-26 | 2021-04-13 | 石药集团圣雪葡萄糖有限责任公司 | 一种提高阿卡波糖发酵产量的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1178837A (zh) | 1998-04-15 |
| CA2215605A1 (fr) | 1998-03-13 |
| US6130072A (en) | 2000-10-10 |
| KR100463738B1 (ko) | 2005-05-03 |
| JPH10127298A (ja) | 1998-05-19 |
| EP0829541A2 (fr) | 1998-03-18 |
| HU223576B1 (hu) | 2004-09-28 |
| HUP9701539A2 (hu) | 1998-07-28 |
| JP4623766B2 (ja) | 2011-02-02 |
| HU9701539D0 (en) | 1997-10-28 |
| DK0829541T3 (da) | 2004-07-19 |
| KR19980024611A (ko) | 1998-07-06 |
| EP0829541B1 (fr) | 2004-04-21 |
| IL121733A0 (en) | 1998-02-22 |
| CA2215605C (fr) | 2007-05-08 |
| ATE264919T1 (de) | 2004-05-15 |
| CN1113966C (zh) | 2003-07-09 |
| TW349124B (en) | 1999-01-01 |
| JP2008054688A (ja) | 2008-03-13 |
| EP0829541A3 (fr) | 1999-12-08 |
| ES2217354T3 (es) | 2004-11-01 |
| DE19637591A1 (de) | 1998-03-19 |
| DE59711536D1 (de) | 2004-05-27 |
| PT829541E (pt) | 2004-09-30 |
| HUP9701539A3 (en) | 2003-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008054688A (ja) | アカルボースの製造のためのオスモル濃度制御発酵方法 | |
| US6620598B2 (en) | Process for preparing O-acetyl-L serine by fermentation | |
| Bhatnagar et al. | Role of the carbon source in regulating chloramphenicol production by Streptomyces venezuelae: studies in batch and continuous cultures | |
| Hellenbroich et al. | Cultivation of Tetrahymena thermophila in a 1.5-m 3 airlift bioreactor | |
| JP4149253B2 (ja) | 微生物の低温培養方法 | |
| SU974817A1 (ru) | Способ получени L-треонина | |
| CN102399845A (zh) | 基于尾气中co2浓度的维生素b12发酵生产控制工艺 | |
| US6197560B1 (en) | Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid | |
| EP2287324A2 (fr) | Procédés de fermentation presentant de faibles concentrations en nutriments contenant du carbone ou de l'azote | |
| CN116042753B (zh) | 一种玉米浆菌体蛋白复合水解液的制备方法及l-异亮氨酸的制备方法 | |
| CN112662713B (zh) | 一种高密度发酵生产l-赖氨酸的培养基及其方法 | |
| US6500651B1 (en) | Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid | |
| RU2084520C1 (ru) | Штамм бактерий brevibacterium flavum - продуцент l-глутамина (варианты) | |
| US4326030A (en) | Process for the production of pyruvic acid and citric acid | |
| KR950007222B1 (ko) | 미생물발효에 의한 l-로이신의 생산 | |
| KR20000002408A (ko) | 글루탐산을 생산하는 미생물 및 이를 이용한 글루탐산의 제조방법 | |
| Junker et al. | Production of indole diterpenes by Aspergillus alliaceus | |
| SU1565888A1 (ru) | Способ получени кератиназы | |
| Hopf et al. | Ambruticin S production in amino acid rich media | |
| KR0169061B1 (ko) | 배양조건 최적화를 통한 자일리톨의 제조방법 | |
| Leonhartsberger et al. | Use of collagen hydrolysate as a complex nitrogen source for the synthesis of penicillin by Penicillium chrysogenum | |
| SU1325074A1 (ru) | Штамм дрожжей SснIZоSасснаRомYсеS ромве ВКПМ У-441,используемый в хлебопечении | |
| SU1713929A1 (ru) | Способ получени L-аспарагиназы | |
| KR0144641B1 (ko) | 발효에 의한 l-로이신의 제조방법 | |
| GB1603887A (en) | Pyruvic acid and citric acid production and microorganisms for use therein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |